Renal Cancers Terminated Phase 3 Trials for Vitespen (DB06400)

Also known as: Renal Cancer / Kidney Cancer / Renal malignant neoplasm / Renal neoplasms malignant / Cancer of Kidney

IndicationStatusPhase
DBCOND0044624 (Renal Cancers)Terminated3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00126178Clinical Trial Studying a Personalized Cancer Vaccine in Patients With Non-metastatic Kidney CancerTreatment